Full Text
HTA57 Impact of China's NRDL Value-Rating System on Reimbursement and Pricing of Innovative Therapies

Abstract

Authors

Wenting Zhang Allen Liu Ningrui Zhang

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×